Australian Clinical Labs Limited (ACL.AX)
AUD 3.49
(-3.32%)
AUD 3.49
(-3.32%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 23.93 Million AUD | -33.33% |
| 2023 | 35.9 Million AUD | -79.86% |
| 2022 | 178.24 Million AUD | 195.24% |
| 2021 | 60.37 Million AUD | 46.34% |
| 2020 | 41.25 Million AUD | 492.01% |
| 2019 | -10.52 Million AUD | -16.78% |
| 2018 | -9.01 Million AUD | 62.5% |
| 2017 | -24.03 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 4.95 Million AUD | 100.0% |
| 2024 FY | 23.93 Million AUD | -33.33% |
| 2024 Q3 | 9.49 Million AUD | 91.66% |
| 2024 Q1 | 2.47 Million AUD | -76.37% |
| 2024 Q4 | 9.49 Million AUD | 0.0% |
| 2023 Q4 | 10.48 Million AUD | 100.0% |
| 2023 FY | 35.9 Million AUD | -79.86% |
| 2023 Q3 | 5.24 Million AUD | -79.39% |
| 2023 Q1 | 12.71 Million AUD | -73.54% |
| 2023 Q2 | 25.42 Million AUD | 100.0% |
| 2022 Q2 | 130.21 Million AUD | 100.0% |
| 2022 Q1 | 65.1 Million AUD | 1872.94% |
| 2022 FY | 178.24 Million AUD | 195.24% |
| 2022 Q4 | 48.03 Million AUD | 100.0% |
| 2022 Q3 | 24.01 Million AUD | -81.56% |
| 2021 FY | 60.37 Million AUD | 46.34% |
| 2021 Q3 | 1.65 Million AUD | -97.11% |
| 2021 Q2 | 57.07 Million AUD | 100.0% |
| 2021 Q4 | 3.3 Million AUD | 100.0% |
| 2021 Q1 | 28.53 Million AUD | -35.81% |
| 2020 Q2 | -3.2 Million AUD | -6300.0% |
| 2020 FY | 41.25 Million AUD | 492.01% |
| 2020 Q4 | 44.45 Million AUD | 114.99% |
| 2020 Q3 | 20.67 Million AUD | 746.17% |
| 2020 Q1 | -50 Thousand AUD | 0.0% |
| 2019 FY | -10.52 Million AUD | -16.78% |
| 2018 FY | -9.01 Million AUD | 62.5% |
| 2017 FY | -24.03 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| BCAL Diagnostics Limited | -6.4 Million AUD | 473.958% |
| Genetic Signatures Limited | -17.86 Million AUD | 233.994% |
| Genetic Technologies Limited | -12.01 Million AUD | 299.164% |
| Healius Limited | -645.8 Million AUD | 103.706% |
| Imagion Biosystems Limited | -12.47 Million AUD | 291.872% |
| Integral Diagnostics Limited | -60.69 Million AUD | 139.431% |
| INOVIQ Ltd | -6.55 Million AUD | 465.162% |
| Microba Life Sciences Limited | -19.93 Million AUD | 220.039% |
| Monash IVF Group Limited | -6.52 Million AUD | 466.692% |
| Rhythm Biosciences Limited | -6.85 Million AUD | 449.057% |
| Sonic Healthcare Limited | 511.09 Million AUD | 95.317% |